Aakaar Medical Technologies to List on NSE SME on 27 June After 2.28× Oversubscribed IPO
By HDFC SKY | Updated at: Jan 14, 2026 12:22 PM IST
Mumbai, 26 June 2025: Aakaar Medical Technologies Ltd is scheduled to make its market debut on the NSE Emerge platform on Friday, 27 June 2025, following a robust investor response to its ₹27 crore initial public offering (IPO). The issue, which closed on 24 June, was subscribed 2.28 times, highlighting notable demand from institutional, non-institutional, and retail participants.
Final IPO Subscription Status as on 24 June
By the end of bidding at 6:19 PM on 24 June, the IPO attracted 57,00,800 bids against an available 24,96,000 shares, with a total of 1,637 applications received across all categories.
Category-Wise Subscription:
| Category | Shares Offered | Shares Bid For | Subscription | Applications |
|---|---|---|---|---|
| QIB | 7,12,000 | 24,96,000 | 3.51x | 7 |
| NII | 5,36,000 | 7,93,600 | 1.48x | 123 |
| Retail | 12,48,000 | 24,11,200 | 1.93x | 1,507 |
| Total | 24,96,000 | 57,00,800 | 2.28x | 1,637 |
Issue Structure and Capital Deployment
The IPO, amounting to ₹27 crore, is a purely fresh issue comprising 37.5 lakh equity shares, with no offer-for-sale (OFS) involved. The proceeds are earmarked for business expansion and general corporate purposes, as outlined in the red herring prospectus.
Company Overview
Established in 2013 and based in Mumbai, Aakaar Medical Technologies Ltd is involved in the manufacturing of medical devices and dermatological ointments, with a primary focus on aesthetic treatment solutions. The company caters to a growing segment within the healthcare and cosmetic dermatology market.
Post-IPO Shareholding Pattern
Following allotment, the ownership of the company stands as follows:
- Promoters and Promoter Group hold 67.01% of the total equity share capital, with no encumbrances or pledged shares.
- Public Shareholding stands at 32.99%, comprising institutions, individuals, NRIs, AIFs, and HUFs.
Notably, alternate investment funds such as AARTH AIF Growth Fund and India Equity Fund hold stakes above 1% each, reflecting institutional confidence in the company.
REF: https://nsearchives.nseindia.com/content/equities/SHP_AAKAAR.pdf
Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com
Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations
